SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-17-001412
Filing Date
2017-03-07
Accepted
2017-03-07 16:06:11
Documents
3
Period of Report
2017-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g8k-2016earningspressrelease.htm 8-K 40175
2 EX-99.1 ex99_1earningspressrelease.htm EX-99.1 216965
3 GRAPHIC ex991earningspressrelea001.jpg GRAPHIC 4219
  Complete submission text file 0001558370-17-001412.txt   264277
Mailing Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142
Business Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 17672008
SIC: 2836 Biological Products, (No Diagnostic Substances)